Coherus BioSciences, Inc.·4

May 22, 4:30 PM ET

Viret Jean-Frederic 4

4 · Coherus BioSciences, Inc. · Filed May 22, 2020

Insider Transaction Report

Form 4
Period: 2020-05-20
Viret Jean-Frederic
Chief Financial Officer
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2020-05-20$17.66/sh1,278$22,56946,567 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.
  • [F2]Includes 31,250 restricted stock units.
  • [F3]Includes 1,004 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4